|
|
|
|
|
|
by svara
30 days ago
|
|
|
It's not black and white- in pharma there are notable sources for investment that are not private, e.g. for orphan diseases that would otherwise not see enough investment due to lack of profitability. But here's a mechanism to mobilize private capital for those diseases that are. Again, the investment needed boogles the mind, around 10B currently, for a single drug. You're asking someone to pay that money and allowing others to reap the rewards. Why wouldn't everyone want to be the one who didn't pay the money? |
|
|
These are made up numbers though. 99% of that is overheads of a massive corporation. A tiny fraction of 10B would pay for all the brightest minds in teh world for a decade. Another tiny fraction to pay for a lab and lab techs.